Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 83,400 | 72,000 | 48,400 | 170,500 | 116,600 |
| Depreciation Amortization | 190,000 | 126,200 | 62,100 | 235,600 | 174,800 |
| Income taxes - deferred | -700 | -7,700 | -4,500 | 2,400 | -2,900 |
| Accounts receivable | 83,600 | 61,600 | 99,600 | N/A | 111,800 |
| Accounts payable and accrued liabilities | -64,500 | -64,900 | -8,800 | -38,300 | -122,100 |
| Other Working Capital | -79,000 | -46,700 | 101,300 | -67,400 | -85,000 |
| Other Operating Activity | 42,800 | 67,300 | -48,500 | 107,700 | 54,700 |
| Operating Cash Flow | $255,600 | $207,800 | $249,600 | $410,500 | $247,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -162,400 | -99,700 | -43,200 | -213,500 | -153,800 |
| Net Acquisitions | -182,700 | -182,300 | -1,700 | -13,700 | -8,700 |
| Sale Of Investment | 10,300 | 0 | 0 | 3,600 | 3,600 |
| Other Investing Activity | -3,100 | -3,100 | 0 | 0 | 0 |
| Investing Cash Flow | $-337,900 | $-285,100 | $-44,900 | $-223,600 | $-158,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,103,700 | 1,103,700 | N/A | 1,914,600 | 958,500 |
| Debt Issued | -15,700 | -9,300 | -5,900 | -21,700 | -17,000 |
| Dividend Paid | -104,400 | -69,800 | -35,300 | -138,900 | -104,400 |
| Other Financing Activity | -958,300 | -958,300 | -1,200 | -1,914,000 | -958,800 |
| Financing Cash Flow | $25,300 | $66,300 | $-42,400 | $-160,000 | $-121,700 |
| Beginning Cash Position | 246,500 | 246,500 | 246,500 | 219,600 | 219,600 |
| End Cash Position | 189,500 | 235,500 | 408,800 | 246,500 | 186,900 |
| Net Cash Flow | $-57,000 | $-11,000 | $162,300 | $26,900 | $-32,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 255,600 | 207,800 | 249,600 | 410,500 | 247,900 |
| Capital Expenditure | -175,500 | -104,300 | -44,700 | -214,900 | -155,100 |
| Free Cash Flow | 80,100 | 103,500 | 204,900 | 195,600 | 92,800 |